HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A phosphotyrosine switch determines the antitumor activity of ERβ.

Abstract
Estrogen receptors ERα and ERβ share considerable sequence homology yet exert opposite effects on breast cancer cell proliferation. While the proliferative role of ERα in breast tumors is well characterized, it is not clear whether the antitumor activity of ERβ can be mobilized in breast cancer cells. Here, we have shown that phosphorylation of a tyrosine residue (Y36) present in ERβ, but not in ERα, dictates ERβ-specific activation of transcription and is required for ERβ-dependent inhibition of cancer cell growth in culture and in murine xenografts. Additionally, the c-ABL tyrosine kinase and EYA2 phosphatase directly and diametrically controlled the phosphorylation status of Y36 and subsequent ERβ function. A nonphosphorylatable, transcriptionally active ERβ mutant retained antitumor activity but circumvented control by upstream regulators. Phosphorylation of Y36 was required for ERβ-mediated coactivator recruitment to ERβ target promoters. In human breast cancer samples, elevated phosphorylation of Y36 in ERβ correlated with high levels of c-ABL but low EYA2 levels. Furthermore, compared with total ERβ, the presence of phosphorylated Y36-specific ERβ was strongly associated with both disease-free and overall survival in patients with stage II and III disease. Together, these data identify a signaling circuitry that regulates ERβ-specific antitumor activity and has potential as both a prognostic tool and a molecular target for cancer therapy.
AuthorsBin Yuan, Long Cheng, Huai-Chin Chiang, Xiaojie Xu, Yongjian Han, Hang Su, Lingxue Wang, Bo Zhang, Jing Lin, Xiaobing Li, Xiangyang Xie, Tao Wang, Rajeshwar R Tekmal, Tyler J Curiel, Zhi-Min Yuan, Richard Elledge, Yanfen Hu, Qinong Ye, Rong Li
JournalThe Journal of clinical investigation (J Clin Invest) Vol. 124 Issue 8 Pg. 3378-90 (Aug 2014) ISSN: 1558-8238 [Electronic] United States
PMID24960160 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • ESR1 protein, human
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Intracellular Signaling Peptides and Proteins
  • Mutant Proteins
  • Nuclear Proteins
  • Recombinant Proteins
  • Tumor Suppressor Proteins
  • Phosphotyrosine
  • Proto-Oncogene Proteins c-abl
  • EYA2 protein, human
  • Protein Tyrosine Phosphatases
Topics
  • Animals
  • Breast Neoplasms (genetics, metabolism, pathology)
  • Disease-Free Survival
  • Estrogen Receptor alpha (metabolism)
  • Estrogen Receptor beta (chemistry, genetics, metabolism)
  • Female
  • Gene Knockdown Techniques
  • Heterografts
  • Humans
  • Intracellular Signaling Peptides and Proteins (metabolism)
  • MCF-7 Cells
  • Mice
  • Mice, 129 Strain
  • Mutant Proteins (chemistry, genetics, metabolism)
  • Nuclear Proteins (metabolism)
  • Phosphotyrosine (chemistry)
  • Prognosis
  • Protein Tyrosine Phosphatases (metabolism)
  • Proto-Oncogene Proteins c-abl (antagonists & inhibitors, genetics, metabolism)
  • Recombinant Proteins (chemistry, genetics, metabolism)
  • Signal Transduction
  • Transcriptional Activation
  • Tumor Suppressor Proteins (chemistry, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: